Is MacroGenics, Inc. technically bullish or bearish?
2025-09-20 19:30:09As of 22 August 2025, the technical trend for MacroGenics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals. The MACD is mildly bullish on both weekly and monthly time frames, while the moving averages indicate a mildly bearish trend on the daily. The Bollinger Bands present a bullish signal weekly but bearish monthly, and the KST is bullish weekly but bearish monthly. The Dow Theory shows a mildly bearish stance weekly and mildly bullish monthly. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 4.85% and 13.82%, respectively, but has significantly underperformed over longer periods, including a year-to-date return of -46.77% compared to the S&P 500's 12.22%....
Read MoreIs MacroGenics, Inc. overvalued or undervalued?
2025-09-20 18:06:32As of 7 March 2024, the valuation grade for MacroGenics, Inc. has moved from attractive to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 1.42, an EV to EBIT of 0.37, and an EV to EBITDA of 0.40, which suggest that the market is pricing the stock higher than its underlying financial performance justifies. When compared to peers, MacroGenics shows a notably poor performance with a valuation of -3.0562, while KalVista Pharmaceuticals, Inc. has a similar risky rating at -4.3845, and Coherus BioSciences, Inc. is at -1.0829. This indicates that MacroGenics is not only struggling relative to its peers but also reflects a broader trend of underperformance, as evidenced by its year-to-date return of -46.77% compared to the S&P 500's 12.22%. Overall, the combination of its valuation m...
Read More





